Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine

Psychiatry Research

Volumn 72, Issue 3, 1997, Pages 161-166

  Galletly, Cherrie A ^a   Clark, C Richard ^b   McFarlane, Alexander C ^a   Weber, Darren L ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Cognition; Negative symptoms; Positive symptoms

Indexed keywords

CLOZAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; NEGATIVE SYNDROME; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; QUALITY OF LIFE; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC LANGUAGE; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME; VERBAL BEHAVIOR;

EID: 0030691208     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(97)00062-0     Document Type: Article

References (31)

1. Benton, A.L., Hamsher, K.deS., 1989. Multilingual Aphasia Examination. AJA Associates, Iowa City, Iowa.
2. Braff, D.L., Heaton, R., Kuck, J., Cullum, M., Moranville, J., Grant, I., Zisook, S., 1991. The generalised pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results. Archives of General Psychiatry 48, 891-898.
3. Breier, A., Schreiber, J.L., Dyer, J., Pickar, D., 1991. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Archives of General Psychiatry 48, 239-246.
4. Brekke, J.S., Raine, A., Ansel, M., Lencz, T., Bird, L., 1997. Neuropsychological and psychophysiological correlates of psychosocial functioning in schizophrenia. Schizophrenia Bulletin 23, 19-28.
5. Brown, S., Roe, M., Lane, A., Gervin, M., Morris, M., Kinsella, A., Larkin, C., O'Callaghan, E., 1996. Quality of life in schizophrenia - relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatrica Scandinavica 94, 118-124.
6. Buchanan, R.W., Holstein, C., Breier, A., 1994. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biological Psychiatry 36, 717-725.
7. Buschke, H., Fuld, P.A., 1974. Evaluating storage, retention and retrieval in disordered memory and learning. Neurology 11, 1019-1025.
8. Crawford, J.R., Besson, A.O., Bremner, M., Ebmeier, K.P., Cochrane, R.H.B., Kirkwood, K., 1992. Estimation of premorbid intelligence in schizophrenia. British Journal of Psychiatry 161, 69-74.
9. Daniel, D.G., Goldberg, T.E., Weinberger, D.R., Kleinman, J.E., Pickar, D., Lubick, L.J., Williams, T.S., 1996. Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study. American Journal of Psychiatry 153, 417-419.
10. Endicott, J., Spitzer, R.L., 1978. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry 35, 837-844.
11. Gallhofer, B., Bauer, U., Lis, S., Kreiger, S., Gruppe, H., 1996. Cognitive dysfunction in schizophrenia - comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. European Neuropsychopharmacology 6, 13-20.
12. Gold, J.M., Weinberger, D.R., 1995. Cognitive deficits and the neurobiology of schizophrenia. Current Opinion in Neurobiology 5, 225-230.
13. Goldberg, T.E., Ragland, J.D., Fuller, T.E., Gold, J.M., Bigelow, L.B., Weinberger, D.R., 1990. Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Archives of General Psychiatry 47, 1066-1072.
14. Goldberg, T.E., Greenberg, R.D., Griffin, S.J., Grold, J.M., Kleinman, J.E., Pickar, D., Schulz, S.C., Weinberger, D.R., 1993. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. British Journal of Psychiatry 62, 43-48.
15. Grace, J., Bellus, S.B., Raulin, M.L., Herz, M.I., Priest, B.L., Brenner, V., Donnelly, K., Smith, P., Gunn, S., 1996. Longterm impact of clozapine and psychosocial treatment on psychiatric symptoms and cognitive functioning. Psychiatric Services 47, 41-45.
16. Hagger, C., Buckley, P., Kenny, J.T., Friedman, L., Ubogy, D., Meltzer, H.Y., 1993. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry 34, 702-712.
17. Hammer, M.A., Katsanis, J., Iacono, W.G., 1995. The relationship between negative symptoms and neuropsychological performance. Biological Psychiatry 37, 828-830.
18. Hawkins, K.A., Hoffman, R.E., Quinlan, D.M., Rakfeldt, J., Docherty, N.M., Sledge, W.H., 1997. Cognition, negative symptoms and diagnosis - a comparison of schizophrenic, bipolar and control samples. Journal of Neuropsychiatry and Clinical Neuroscience 9, 81-89.
19. Heinrichs, D.W., Hanlon, T.E., Carpenter, W.T., 1984. The quality of life scale: an instrument for rating the schizophrenia deficit syndrome. Schizophrenia Bulletin 3, 388-398.
20. Hoff, A.L., Faustman, W.O., Wieneke, M., Espinoza, S., Costa, M., Wolkowitz, O., Csernansky, J.G., 1996. The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients. Neuropsychopharmacology 15, 361-369.
21. Kay, S.R., Fizbein, A., Opler, L.A., 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 2, 261-276.
22. Lee, M.A., Thompson, P.A., Meltzer, H.Y., 1994. Effects of clozapine on cognitive function in schizophrenia. Journal of Clinical Psychiatry 55, 82-87.
23. Lezak, M.D., 1995. Neuropsychological Assessment. Oxford University Press, New York.
24. Lindenmayer, J., Bernstein-Hyman, R., Grochowski, S., Bark, N., 1995. Psychopathology of schizophrenia: initial validation of a 5-factor model. Psychopathology 28, 22-31.
25. Meltzer, H.Y., Bastani, B., Young Kwon, K., Ramirez, L.F., Burnett, S., Sharpe, J., 1989. A prospective study of clozapine in treatment-resistant schizophrenic patients. Psychopharmacology 99, S68-72.
26. Meltzer, H.Y., 1995. Multiple-outcome criteria in schizophrenia: an overview of outcome with clozapine. European Psychiatry 10, 19s-25s.
27. Morrison-Stewart, S.L., Williamson, P.C., Corning, W.C., Kutcher, S.P., Snow, W.G., Merskey, H., 1992. Frontal and non-frontal lobe neuropsychological test performance and clinical symptomatology in schizophrenia. Psychological Medicine 22, 353-359.
28. Peterson, L.R., Peterson, M.J., 1959. Short term retention of individual verbal items. Journal of Experimental Psychology 58, 193-198.
29. Talland, G.A., 1965. Deranged Memory. Academic Press, New York.
30. Wechsler, D., 1974. WISC-R Manual. Wechsler Intelligence Scale for Children - Revised. Psychological Corporation, New York.
31. Wechsler, D., 1981. WAIS-R Manual. Wechsler Adult Intelligence Scale - Revised. Psychological Corporation, New York.